Involvement of CB1 cannabinoid receptors in the EDHF-dependent vasorelaxation in rabbits

British Journal of Pharmacology

Volumn 126, Issue 6, 1999, Pages 1383-1386

  Niederhoffer, Nathalie ^a   Szabo, Bela ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acetylcholine; Cannabinoid receptor; EDHF; Endothelium; Pithed rabbit; Smooth muscle relaxation

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ACETYLCHOLINE; CANNABINOID; CANNABINOID RECEPTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; RIMONABANT; TETRYLAMMONIUM; BIOLOGICAL FACTOR; CALCIUM CHANNEL BLOCKING AGENT; DIMETHYL SULFOXIDE; DRUG RECEPTOR; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; ENZYME INHIBITOR; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NITRIC OXIDE SYNTHASE; PIPERIDINE DERIVATIVE; POTASSIUM CHANNEL; PYRAZOLE DERIVATIVE; SOLVENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HYPERPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASODILATATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; BIOLOGICAL FACTORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIMETHYL SULFOXIDE; ENZYME INHIBITORS; MORPHOLINES; NAPHTHALENES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PIPERIDINES; POTASSIUM CHANNELS; PYRAZOLES; RABBITS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SOLVENTS; TETRAETHYLAMMONIUM; VASODILATION; VASODILATOR AGENTS;

EID: 0032589043     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702452     Document Type: Article

References (21)

1. 1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br. J. Pharmacol., 123, 968-974.
2. COWAN, C.L., PALACINO, J.J., NAJIBI, S. & COHEN, R.A. (1993). Potassium channel-mediated relaxation to acetylcholine in rabbit arteries. J. Pharmacol. Exp. Ther., 266, 1482-1489.
3. 2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery. Br. J. Pharmacol., 120, 695-701.
4. + is an endothe-lium-derived hyperpolarizing factor in rat arteries. Nature, 396, 269-272.
5. EDWARDS, G. & WESTON, A.H. (1998). Endothelium-derived hyperpolarizing factor - A critical appraisal. Prog. Drug Res., 50, 107-133.
6. FULTON, D. & QUILLEY, J. (1998). Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. J. Pharmacol. Exp. Ther., 286, 1146-1151.
7. GARLAND, C.J., PLANE, F., KEMP, B.K. & COCKS, T.M. (1995). Endothelium-dependent hyperpolarization: A role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.
8. LISCHKE, V., BUSSE, R. & HECKER M. (1995). Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br. J. Pharmacol., 115, 969-974.
9. MÜGGE, A., LOPEZ, J.A.G., PIEGORS, D.J., BREESE, K.R. & HEISTAD, D.D. (1991). Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine. Am. J. Physiol., 260, H242-H247.
10. NIEDERHOFFER, N. & SZABO, B. (1999). Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br. J. Pharmacol., 126, 457-466.
11. PERSSON, M.G., WIKLUND, N.P. & GUSTAFSSON, L.E. (1991). Nitric oxide requirement for vasomotor nerve-induced vasodilatation and modulation of resting blood flow in muscle microcirculation. Acta Physiol. Scand., 141, 49-56.
12. PLANE, F., HOLLAND, M., WALDRON, G.J., GARLAND, C.J. & BOYLE, J.P. (1997). Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br. J. Pharmacol., 121, 1509-1511.
13. PRATT, P.F., HILLARD, C.J., EDGEMOND, W.S. & CAMPBELL, W.B. (1998). N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am. J. Physiol., 274, H375-H381.
14. RANDALL, M.D., ALEXANDER, S.P.H., BENNETT, T., BOYD, E.A., FRY, J.R., GARDINER, S.M., KEMP, P.A., MCCULLOCH, A.I. & KENDALL, D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Comm., 229, 114-120.
15. RANDALL, M.D. & KENDALL, D.A. (1997). Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur. J. Pharmacol., 335, 205-209.
16. RANDALL, M.D. & KENDALL, D.A. (1998). Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol. Sci., 19, 55-58.
17. RANDALL, M.D., MCCULLOCH, A.I. & KENDALL, D.A. (1997). Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. Eur. J. Pharmacol., 333, 191 197.
18. REES, D.D., PALMER, R.M.J., SCHULZ, R., HODSON, H.F. & MONCADA, S. (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
19. WHITE, R. & HILEY, C.R. (1997). A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol., 122, 1573-1584.
20. WHITE, R. & HILEY, C.R. (1998). The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br. J. Pharmacol., 125, 533-541.
21. ZYGMUNT, P.M., HÖGESTÄTT, E.D., WALDECK, K., EDWARDS, G., KIRKUP, A.J. & WESTON A.H. (1997). Studies on the effects of anandamide in rat hepatic artery. Br. J. Pharmacol., 122, 1679-1686.